Phase
Condition
N/ATreatment
Hydra Transcatheter Aortic Valve System
Clinical Study ID
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with severe symptomatic native aortic valve stenosis and candidates for theTAVI procedure based on the evaluation of the Heart Team
Ability to understand and provide informed consent for inclusion in the study
Exclusion
Exclusion Criteria:
Contraindication to TAVI: e.g. evidence of intracardiac mass, thrombus orvegetation, endocarditis.
Refusal by the patient to participate in the study
High probability of non-adherence to required follow-ups
Study Design
Study Description
Connect with a study center
Fondazione Poliambulanza Istituto
Brescia, 25124
ItalyActive - Recruiting
Montevergine Clinic, Mercogliano, Italy
Mercogliano, 83013
ItalyActive - Recruiting
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milano, 20157
ItalySite Not Available
Università degli studi di Padova
Padova, 35122
ItalySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.